Morse Faria

Dr. Morse Faria


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Antibodies
Verified
Journal Article
Open access
PDF file
MFMorse Faria
Morse Faria
MPMarlking Peay
Marlking Peay
BLBrandon Lam
Brandon Lam
EMEric Ma
Eric Ma
MYMoucun Yuan
Moucun Yuan
ARAnton Rosenbaum
Anton Rosenbaum
Bioanalysis of complex biotherapeutics, such as antibody-drug conjugates (ADCs), is challenging and requires multiple assays to describe their pharmacokinetic (PK) profiles. To enable exposure-safety and exposure-efficacy analyses, as well as to understand the metabolism of ADC therapeutics, three bioanalytical methods are typically employed: Total Antibody, Antibody Conjugated Toxin or Total ADC and Unconjugated Toxin. MEDI4276 is an ADC comprised of biparatopic humanized antibody attached via a protease-cleavable peptide-based maleimidocaproyl linker to a tubulysin toxin (AZ13599185) with an approximate average drug-antibody ratio of 4. The conjugated payload of MEDI4276 can undergo ester hydrolysis to produce the conjugated payload AZ13687308, leading to the formation of MEDI1498 (de-acetylated MEDI4276). In this report, we describe the development, validation and application of three novel multiplex bioanalytical methods. The first ligand-binding liquid chromatography coupled with tandem mass spectrometry (LBA-LC-MS/MS) method was developed and validated for simultaneous measurement of total antibody and total ADC (antibody-conjugated AZ13599185) from MEDI4276. The second LBA-LC-MS/MS assay quantified total ADC (antibody-conjugated AZ13687308) from MEDI1498. The third multiplex LC-MS/MS assay was used for simultaneous quantification of unconjugated AZ13599185 and AZ13687308. Additional stability experiments confirmed that quantification of the released warhead in the presence of high concentrations of MEDI4276 was acceptable. Subsequently, the assays were employed in support of a first-in-human clinical trial (NCT02576548).

25 April 2018
Verified
Book Chapter
Open access
PDF file
MFMorse Faria
Morse Faria
MHMatthew Halquist
Matthew Halquist
Internal standardization plays a critical role in the performance of a bioanalytical method. There has been a tremendous increase in the popularity of using liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for quantitative bioanalysis of protein molecules. Protein, being too large to be directly analyzed by LC-MS/MS, is proteolyzed and a characteristic peptide is used as a surrogate analyte for quantification. Internal standardization in small molecules’ analysis is straightforward, i.e., either a stable labeled isotope (SIL) form of the analyte or a structural analogue is used. As protein quantification involves protein digestion to yield peptides, there are more options for internal standardization. Currently, internal standard selection is based on the availability of the internal standards and the sample preparation workflow. A SIL-form of the analyte protein is the ideal internal standard. However, its use is limited due to cost and commercial availability. Alternatively, a SIL form the surrogate peptide analyte or a cleavable SIL-peptide can be used as an IS. For preclinical bioanalysis of humanized IgG antibody-based drugs, a universal SIL analogue protein has been effectively used as an internal standard. This chapter focuses on internal standardization for the quantitative analysis of proteins, such as biotherapeutics and biomarkers, using LC-MS/MS.

15 January 2020 in Journal of Applied Bioanalysis
Verified
Journal Article
Open access
MFMorse Faria
Morse Faria
[icon name="unlock"] OPEN-ACCESS [icon name="eye"] PEER-REVIEWED FOREWORD Morse Faria PPD Laboratories, Richmond, VA 23230, USA. Journal of Applied Bioanalysis. Vol.6.... Antibody-based biotherapeutics are the fastest growing category of therapeutics entering clinical studyies.

15 August 2020 in Journal of Applied Bioanalysis
Verified
Journal Article
Open access
MFMorse Faria
Morse Faria
OIOmnia Ismaiel
Omnia Ismaiel
JWJames Waltrip
James Waltrip
TMTom Mariannino
Tom Mariannino
MYMoucun Yuan
Moucun Yuan
PKPathanjali Kadiya
Pathanjali Kadiya
[icon name="unlock"] OPEN-ACCESS [icon name="eye"] PEER-REVIEWED ORIGINAL RESEARCH Morse Faria1,*, Omnia A. Ismaiel1,2, James Waltrip1, Tom Mariannino1, Moucun Yuan1, William... This paper describes a validated method to simultaneously measure tanespimycin and its active metabolite in human plasma by LC-MS/MS.